References
- Preston F E, Ward J D, Marcola B H, Porter M R, Timperley W R, O'Malley B C. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; i: 238–40
- Burrows A W, Chavin S I, Hockaday T DR. Plasma thromboglobulin concentrations in diabetes mellitus. Lancet 1978; i: 235–37
- Borsey D O, Dawes J, Fraser D M, Prowse C V, Elton R A, Clarke B F. Plasma beta-thromboglobulin in diabetes mellitus. Diabetolo-gia 1980; 18: 353–57
- Elving D, Casparie A F, Miedema K, Russchen C J. Plasma beta-thromboglobulin in diabetics with and without microangiopathic complications. Diabetologia 1981; 21: 160–61
- Ek I, Thunell S, Blomback N. Enhanced in vivo platelet activation in diabetes mellitus. Scand J Haematol 1982; 29: 185–91
- Files J C, Malpass T W, Yee E K, Ritchie J L, Harker L A. Studies of human platelet alpha-granule release in vivo. Blood 1981; 58: 607–18
- Witte L D, Kaplan K L, Nossel H L, Lages B A, Weiss H J, Goodman D S. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 1978; 42: 402–9
- Harker L A, Malpass T W, Branson H E, Hessel E A, II, Slichter S J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective granule release. Blood 1980; 56: 824–34